Ibifax-c – Indiabulls Pharmaceuticals

Registered App ID 3499257 Class 5 Word

Trademark information

IP India · live record
Application ID
3499257
Status
Registered
Sub status
Not Applicable
Date of application
03 March 2017
Classes
5
Type
Word
Proprietor
Indiabulls Pharmaceuticals Public Tower 1, 14 Th Floor, Indiabulls Finance Centre, Senapati Bapat Marg, Elphinstone West, Mumbai, 400013, Maharashtra, India.
Attorney
M/S. V.A. Associates[16557]204, Pratik Avenue, 2nd Floor, Nehru Road, Vile Parle (East), Mumbai 400 057.
State
Maharashtra
Filing mode
Branch Office
IP office
Mumbai
Used since
—
Valid / upto
03 March 2027

Goods & services

Class 5

Class 5PHARMACEUTICALS, MEDICAL AND VETERINARY PREPARATIONS; SANITARY PREPARATIONS FOR MEDICAL PURPOSES; DIETETIC FOOD AND SUBSTANCES ADAPTED FOR MEDICAL OR VETERINARY USE, FOOD FOR BABIES; DIETARY SUPPLEMENTS FOR HUMANS AND ANIMALS; PLASTERS, MATERIALS FOR DRESSINGS; MATERIAL FOR STOPPING TEETH, DENTAL WAX; DISINFECTANTS; PREPARATIONS FOR DESTROYING VERMIN; FUNGICIDES, HERBICIDES

PR details

INDIABULLS PHARMACEUTICALS LIMITED, TOWER 1, 14TH FLOOR, INDIABULLS FINANCE CENTRE, SENAPATI BAPAT MARG, ELPHINSTONE WEST, MUMBAI, 400013, MAHARASHTRA, INDIA., A COMPANY INCORPORATED UNDER THE COMPANIES ACT, 1956, MANUFACTURERS AND MERCHANTS, (Body Incorporate)

Uploaded documents

Sign in to open
1 Additional Representation Sheet 03 Mar 2017
1 Power of Attorney 03 Mar 2017
2 Additional Representation Sheet 03 Mar 2017
2 Power of Attorney 03 Mar 2017
3 TM-1 03 Mar 2017
4 Reply to Exam Report (MIS-R) 19 Apr 2017
5 Journal Copy 31 May 2019
6 Certificate 08 Aug 2019

Correspondence and notices

1 Hearing Notice (Show Cause) 7723943 · 3814719 04 Feb 2019
2 Tribunal Accepted Notice for : 3499257 7947500 · 3882346 13 Mar 2019

Frequently asked questions

Ibifax-c was applied for on 03 March 2017.

The application was filed by Indiabulls Pharmaceuticals.

Class 5.

As per IP India, the status is Registered.

The listed application ID of Ibifax-c is 3499257.

Trademark attorney M/S. V.A. Associates.